Drug injections miss the mark in obese patients
Patients with large behinds do not derive the biggest benefit from vaccines and other injections into the buttocks, according to a study by Dr. Victoria Chan and colleagues at the Adelaide and Meath Hospital in Dublin, Ireland.
Patients with large behinds do not derive the biggest benefit from vaccines and other injections into the buttocks, according to a study by Dr. Victoria Chan and colleagues at the Adelaide and Meath Hospital in Dublin, Ireland.
Researchers observed 60 obese men and women scheduled for CT scans of the abdomen and pelvis who had received intramuscular medication. They found that 68% of intramuscular injections did not reach the buttock muscles.
The overall success rate of the injections was 32%. The success rate among men was 56% compared with only 8% among women. Compared with men, women typically have a higher amount of fat in their buttocks.
"The amount of fat tissue overlying the muscles exceeds the length of the needles commonly used for these injections," Chan said at the 2005 RSNA meeting.
Her solution? Longer needles.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
